共 20 条
- [3] POLYCLONAL B-CELL ACTIVATION ARISES FROM DIFFERENT MECHANISMS IN LUPUS-PRONE (NZB X NZW)F1 AND MRL MPJ-LPR/LPR MICE [J]. JOURNAL OF IMMUNOLOGY, 1993, 151 (11): : 6509 - 6516
- [4] AN IMMUNOMODULATING ANTIRHEUMATIC DRUG, LOBENZARIT DISODIUM (CCA) - INHIBITION OF POLYCLONAL B-CELL ACTIVATION AND PREVENTION OF AUTOIMMUNE-DISEASE IN MRL/MP-LPR/LPR MICE [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 45 (03): : 366 - 374
- [7] LIPOPOLYSACCHARIDE FROM GRAM-NEGATIVE BACTERIA ENHANCES POLYCLONAL B-CELL ACTIVATION AND EXACERBATES NEPHRITIS IN MRL/LPR MICE [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 82 (03): : 515 - 521
- [8] Masp-1/3 Deficient MRL/Lpr Mice Lack The Alternative Complement Pathway Activation and Are Protected From Development Of Lupus-Like Glomerulonephritis [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S1241 - S1241
- [10] Partial Protection From Lupus-Like Disease by B-Cell Specific Type I Interferon Receptor Deficiency [J]. FRONTIERS IN IMMUNOLOGY, 2021, 11